Publications by authors named "Shude Cui"

Claim this Profile
E
Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial.
Dongmei Ji, Shufang Wang, Wei Yao, Denny Hou, Xiaoyan Wang, Shude Cui

Clin Drug Investig· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
Liang Huang, Da Pang, Hongjian Yang, Wei Li, Shusen Wang, Shude Cui

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.
Hanzhao Yang, Yadong Sun, Peili Wang, Jianghua Qiao, Lianfang Li, Shude Cui

Med Sci Monit· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer: a long-term safety and overall survival update from the randomised, double-blind, placebo-controlled, phase 3 trial.
Qingyuan Zhang, Wei Li, Xichun Hu, Tao Sun, Shude Cui, Cuizhi Geng

Transl Breast Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study).
Jiayu Wang, Li Cai, Yanqiu Song, Tao Sun, Zhongsheng Tong, Shude Cui

Eur J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features and prognosis of breast cancer combined with symptomatic bone marrow metastases: A 10-year, single-center, real-world study of 67 cases.
Limin Niu, Huimin Lv, Mengwei Zhang, Huiai Zeng, Shuzhen Fu, Shude Cui

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment-a retrospective cohort study.
Jiabin Wang, Jianghua Qiao, Yuxia Ruan, Chengzheng Wang, Lianfang Li, Shude Cui

Gland Surg· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China.
Binghe Xu, Huiping Li, Zefei Jiang, Lin Gu, Jinhai Tang, Shude Cui

Chin J Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4.
Binghe Xu, Xichun Hu, Wei Li, Tao Sun, Kunwei Shen, Shude Cui, Cuizhi Geng

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen.
Jiujun Zhu, Dechuang Jiao, Chengzheng Wang, Zhenduo Lu, Xiuchun Chen, Shude Cui

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Lifestyle Habits and Health-Related Quality of Life of Recently Diagnosed Breast Cancer Patients: A Comparison Between Younger and Older Women in China.
Chao Zheng, Li-Xiang Yu, Hong-Ying Jia, Shu-De Cui, Fu-Guo Tian, Cui-Zhi Geng

Front Public Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females.
Liang Li, Xingchen Meng, Liyuan Liu, Yujuan Xiang, Fei Wang, Shude Cui, Cuizhi Geng

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021.
Jiu-Jun Zhu, De-Chuang Jiao, Min Yan, Xu-Hui Guo, Ya-Jie Zhao, Shu-De Cui

Chin Med J (Engl)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical diagnosis and treatment of breast cancer with brain metastases and establishment of a prognostic model: a 10-year, single-center, real-world study of 559 cases.
Limin Niu, Huimin Lv, Mengwei Zhang, Huiai Zeng, Lifeng Wang, Shude Cui

Ann Transl Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XRCC5/6 polymorphisms and their interactions with smoking, alcohol consumption, and sleep satisfaction in breast cancer risk: A Chinese multi-center study.
Li-Xiang Yu, Li-Yuan Liu, Yu-Juan Xiang, Fei Wang, Fei Zhou, Shu-De Cui, Cui-Zhi Geng

Cancer Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021.
De-Chuang Jiao, Jiu-Jun Zhu, Li Qin, Xu-Hui Guo, Ya-Jie Zhao, Shu-De Cui

Chin Med J (Engl)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer.
Jiujun Zhu, Dechuang Jiao, Min Yan, Xiuchun Chen, Chengzheng Wang, Cuizhi Geng, Shude Cui

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study.
Ling Xu, Yinhua Liu, Zhimin Fan, Zefei Jiang, Yunjiang Liu, Shude Cui, Yimin Cui

Front Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.
Benlong Yang, Guosheng Ren, Erwei Song, Da Pan, Jing Zhang, Shude Cui, Cuizhi Geng

Oncologist· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China.
Li Ma, Yunzhe Mi, Shude Cui, Haibo Wang, Peifen Fu, Cuizhi Geng

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
Junjie Li, Keda Yu, Da Pang, Changqin Wang, Jun Jiang, Shude Cui

J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Addendum: Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case-Control Study in Chinese Women.
Yujuan Xiang, Wenzhong Zhou, Xuening Duan, Zhimin Fan, Shu Wang, Shude Cui, Cuizhi Geng

Front Endocrinol (Lausanne)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.
Zhimin Shao, Da Pang, Hongjian Yang, Wei Li, Shusen Wang, Shude Cui

JAMA Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case-Control Study in Chinese Women.
Yujuan Xiang, Wenzhong Zhou, Xuening Duan, Zhimin Fan, Shu Wang, Shude Cui, Cuizhi Geng

Front Endocrinol (Lausanne)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zefei Jiang, Wei Li, Xichun Hu, Qingyuan Zhang, Tao Sun, Shude Cui, Cuizhi Geng

Lancet Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis